Working… Menu
Trial record 1 of 1 for:    1280 0022
Previous Study | Return to List | Next Study

The XENERA™ 1 Study Tests Xentuzumab in Combination With Everolimus and Exemestane in Women With Hormone Receptor Positive and HER2-negative Breast Cancer That Has Spread

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03659136
Recruitment Status : Active, not recruiting
First Posted : September 6, 2018
Last Update Posted : July 23, 2021
Information provided by (Responsible Party):
Boehringer Ingelheim